Barry E Greene insider trades: Sage Therapeutics (SAGE) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Barry reports to the SEC
and 1 more company
Open-market buys and sales
32 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 10, 2022 | SAGE | ↑ Buy | 14,500 | $34.48 | $500K | Direct | Nov 15, 2022 (5d) |
| Aug 5, 2021 | SAGE | ↑ Buy | 23,640 | $43.15 | $1.0M | Direct | Aug 9, 2021 (4d) |
| Jun 16, 2021 | SAGE | ↑ Buy | 8,800 | $56.32 | $496K | Direct | Jun 17, 2021 (1d) |
| Sep 9, 2020 | ALNY | ↓ Sell | 44,530 | $123.23 | $5.5M | Direct | Sep 11, 2020 (2d) |
| Jul 7, 2020 | ALNY | ↓ Sell | 22,265 | $159.99 | $3.6M | Direct | Jul 9, 2020 (2d) |
| May 6, 2020 | ALNY | ↓ Sell | 22,265 | $149.99 | $3.3M | Direct | May 7, 2020 (1d) |
| Oct 22, 2019 | ALNY | ↓ Sell | 58,913 | $89.99 | $5.3M | Direct | Oct 24, 2019 (2d) |
| Mar 14, 2018 | ALNY | ↓ Sell | 38,460 | $143.10 | $5.5M | Direct | Mar 16, 2018 (2d) |
| Oct 2, 2017 | ALNY | ↓ Sell | 85,316 | $125.00 | $10.7M | Direct | Oct 4, 2017 (2d) |
| Sep 20, 2017 | ALNY | ↓ Sell | 76,815 | $100.00 | $7.7M | Direct | Sep 22, 2017 (2d) |
| Aug 1, 2017 | ACOR | ↓ Sell10b5-1 | 10,000 | $21.57 | $216K | Direct | Aug 3, 2017 (2d) |
| Feb 9, 2017 | ACOR | ↓ Sell10b5-1 | 723 | $22.65 | $16K | Direct | Feb 13, 2017 (4d) |
| Jan 3, 2017 | ACOR | ↓ Sell10b5-1 | 3,017 | $19.26 | $58K | Direct | Jan 5, 2017 (2d) |
| Dec 1, 2016 | ALNY | ↓ Sell | 31,825 | $42.99 | $1.4M | Direct | Dec 5, 2016 (4d) |
| May 26, 2015 | ALNY | ↓ Sell | 67,379 | $125.00 | $8.4M | Direct | May 28, 2015 (2d) |
| Apr 2, 2015 | KPTI | ↑ Buy | 3,000 | $29.31 | $88K | Direct | Apr 6, 2015 (4d) |
| Dec 19, 2014 | ALNY | ↓ Sell | 11,200 | $100.00 | $1.1M | Direct | Dec 22, 2014 (3d) |
| Nov 17, 2014 | ALNY | ↓ Sell | 33,200 | $89.63 | $3.0M | Direct | Nov 19, 2014 (2d) |
| Nov 11, 2014 | ALNY | ↓ Sell | 11,100 | $100.00 | $1.1M | Direct | Nov 13, 2014 (2d) |
| May 28, 2013 | ALNY | ↓ Sell | 22,822 | $30.00 | $685K | Direct | May 30, 2013 (2d) |
| Mar 14, 2013 | ALNY | ↓ Sell | 24,058 | $25.00 | $601K | Direct | Mar 18, 2013 (4d) |
| Mar 8, 2013 | ALNY | ↓ Sell | 24,000 | $24.43 | $586K | Direct | Mar 11, 2013 (3d) |
| Feb 21, 2012 | ALNY | ↑ Buy | 1,860 | $10.75 | $20K | Direct | Feb 23, 2012 (2d) |
| Jan 9, 2012 | ALNY | ↑ Buy | 567 | $8.80 | $5K | Direct | Jan 11, 2012 (2d) |
| Dec 12, 2011 | ALNY | ↑ Buy | 699 | $7.15 | $5K | Direct | Dec 14, 2011 (2d) |
| Nov 14, 2011 | ALNY | ↑ Buy | 704 | $7.09 | $5K | Direct | Nov 16, 2011 (2d) |
| Oct 11, 2011 | ALNY | ↑ Buy | 742 | $6.73 | $5K | Direct | Oct 13, 2011 (2d) |
| Aug 13, 2008 | ALNY | ↓ Sell | 35,440 | $33.94 | $1.2M | Direct | Aug 15, 2008 (2d) |
| Oct 24, 2007 | ALNY | ↓ Sell | 21,700 | $30.85 | $669K | Direct | Oct 26, 2007 (2d) |
| Oct 24, 2007 | ALNY | ↓ Sell | 10,580 | $31.13 | $329K | Direct | Oct 26, 2007 (2d) |
| Oct 24, 2007 | ALNY | ↓ Sell | 5,220 | $31.63 | $165K | Direct | Oct 26, 2007 (2d) |
| Oct 31, 2006 | ALNY | ↓ Sell | 12,500 | $20.71 | $259K | Direct | Nov 1, 2006 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Barry E Greene's insider trades
Barry E Greene is President and CEO at Sage Therapeutics (SAGE). Since Oct 31, 2006, Barry has reported 9 open-market purchases worth $2.1M and 23 sales worth $61.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
3 sales (0% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (72 filings), option exercises (26 filings), other transactions (5 filings), shares withheld for taxes (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SAGE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.